English
Specials
Premium
My Alerts
Moneycontrol

Amgen

SYMBOL:AMGN|SECTOR:Health Care|DERIVED:CFD
i
Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices are indicative only and not appropriate for trading purposes. Therefore Moneycontrol doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
$
0
0
3
3
.
5
5
5
5
3
3
5.91 (1.69%)

As on 18 Apr, 2026 | 01:29 IST

Day Range
349.54
356.27
LH
52 Week Range
261.50
391.23
LH
Advance Chart
Open349.39
Previous Close349.39
Beta0.25
High356.27
Low349.54
TTM EPS See historical trend   21.85(+10.24% YoY)
52 Week High391.23
52 Week Low261.50
TTM PE See historical trend    16.26(Low PE)
Mkt. Cap ($ Billion)190.99
Dividend Yield2.95

Advanced Chart

*Delayed by 20 seconds

MC Technicals

Technical rating
i
This represents current trend.
Click here  for disclaimer.
Trend
Bullish
See Details  
Historical Rating  
Moving AveragesBullish
Technical IndicatorsNeutral
Moving Averages CrossoversNeutral

Pivot levels

TypeR1R2R3PPS1S2S3
Classic351.55 353.71 356.17349.09 346.93 344.47 342.31
Fibonacci350.86 351.95 353.71349.09 347.33 346.23 344.47
Camarilla349.81 350.24 350.66349.09 348.97 348.54 348.12

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Moving Averages
Days
5350.69
10349.24
20349.84
50363.61
100348.68
200322.02

Returns

Price Performance
1 Week1.22%
1 Month
-1.62%
3 Months7.53%
YTD8.54%
1 Year28.27%
3 Years43.23%

Financialsin million $

Peers

NamePrice ($)Change%M.Cap(Billion $)TTM PETTM EPSDY52 wk high/lowTechnical Rating
Eli Lilly926.702.51881.4838.3024.210.581,133.95/623.99-0.39Neutral
J&J234.18-0.15564.2321.6810.802.50251.71/146.13-1.67Bearish
AbbVie208.38-0.29368.2020.8410.002.91244.80/168.66-5.19Very Bearish
Merck119.073.13301.5613.278.973.12125.14/73.352.76Bullish
Amgen355.301.69190.9916.2621.852.95391.23/261.50-1.62Bullish
+ See More

Market news

Wall Street indexes hit record highs as oil falls with Strait of Hormuz declared open

April 18, 2026 8:35 AM
Show More

About the company

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin alfa), KYPROLIS, Repatha (evolocumab), Nplate (romiplostim), Vectibix (panitumumab), MVASI (bevacizumab-awwb), Parsabiv (etelcalcetide), EPOGEN (epoetin alfa), KANJINTI (trastuzumab-anns), BLINCYTO (blinatumomab), Aimovig (erenumab-aooe), EVENITY (romosozumab-aqqg), AMGEVITATM (adalimumab), Sensipar/Mimpara (cinacalcet), NEUPOGEN (filgrastim), IMLYGIC (talimogene laherparepvec), Corlanor (ivabradine) and AVSOLA (infliximab-axxq). It focuses on human therapeutics for the treatment of serious illness in the areas of inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience.